The analysis revealed that patients with the higher PSA level presented significantly higher Tim-3 expression on these cells, in which PCa patients with >20 ng/ml PSA levels revealed significantly upregulated level of Tim-3 than the other stages (Fig. 2b). The gene discussed is HAVCR2; the disease is posterior cortical atrophy.